Edgewise Therapeutics (EWTX): Assessing Valuation After an 80% Three-Month Surge in the Share Price [Yahoo! Finance]
Edgewise Therapeutics, Inc. (EWTX)
Company Research
Source: Yahoo! Finance
See our latest analysis for Edgewise Therapeutics. The latest surge takes Edgewise Therapeutics to a share price of $27.29 and caps a powerful stretch, with short term share price momentum now catching up to its strong three year total shareholder return of over 230 percent. If this kind of momentum has your attention, it could be a good time to explore other promising healthcare names using our screener for healthcare stocks Yet with shares still trading at a sizeable discount to analyst targets despite a blockbuster three year run, investors now face a tougher question: is Edgewise Therapeutics still a buying opportunity, or is the market already pricing in the next leg of growth? On a price to book basis, Edgewise Therapeutics trades at 5.2 times its net assets, a level that looks inexpensive against direct peers but elevated versus the wider pharmaceuticals space. The price to book multiple compares the market value of a company to the accounting value of its equity, a
Show less
Read more
Impact Snapshot
Event Time:
EWTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EWTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EWTX alerts
High impacting Edgewise Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
EWTX
News
- Why Edgewise Therapeutics Stock Rocked the Market Today [Yahoo! Finance]Yahoo! Finance
- Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy [Yahoo! Finance]Yahoo! Finance
- Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic CardiomyopathyPR Newswire
- Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing RulesPR Newswire
- Edgewise Therapeutics (NASDAQ:EWTX) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=EWTX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StrMarketBeat
EWTX
Earnings
- 11/6/25 - Beat
EWTX
Sec Filings
- 11/24/25 - Form 4
- 11/24/25 - Form 3
- 11/20/25 - Form 8-K
- EWTX's page on the SEC website